Dynamic shift in localization of UBE3A across developmental stages in an Angelman syndrome mouse model
Neurobiology of Disease · 2025
DOI: 10.1016/j.nbd.2025.106912 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Pooja Kri Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa 3103301, Israel. Hauptthemen laut MEDLINE: Angelman Syndrome, Ubiquitin-Protein Ligases, Brain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Israel Science Foundation.
Abstract (Originalsprache)
The ubiquitin-proteasome pathway (UPP) plays a crucial role in cellular homeostasis by regulating protein degradation. UBE3A, an E3 ubiquitin ligase encoded by the UBE3A gene, is maternally expressed in neurons and linked to neurodevelopmental disorders such as Angelman syndrome (AS) and 15q11-q13 duplication syndrome (Dup15q syndrome). While UBE3A is predominantly nuclear in mature neurons, its dynamic subcellular localization across development and potential mitochondrial role remain poorly understood. Here, we investigate the developmental distribution of UBE3A among nuclear, mitochondrial, and cytosolic compartments in wild-type (WT) and AS mouse brains at embryonic (E16.5), early postnatal (P2), and adult stages. In wild-type neurons, UBE3A is initially distributed evenly across the cytoplasm, mitochondria, and nucleus at E16.5, but later shifts predominantly to the nucleus in adulthood, with a concomitant decline in mitochondrial localization. In contrast, UBE3A in AS shows an aberrant distribution at early developmental stages, reduced nuclear localization and enhanced cytosolic accumulation, and an altered developmental trajectory, with a persistent redistribution toward the cytosol and reduced nuclear accumulation. Our findings provide new insights into the developmental dynamic shift of UBE3A's subcellular localization and suggest a link between UBE3A dysfunction, mitochondrial abnormalities, and AS pathophysiology. Furthermore, these results suggest that in normal conditions, UBE3A has a functional role in mitochondria during early neurodevelopment, which may be disrupted in AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa 3103301, Israel.
- Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa 3103301, Israel. Electronic address: hkaphzan@univ.haifa.ac.il.
Förderung
- Israel Science Foundation
Zitieren
APA
Gupta, P. K., Feuermann, Y., & Kaphzan, H. (2025). Dynamic shift in localization of UBE3A across developmental stages in an Angelman syndrome mouse model. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2025.106912
Vancouver
Gupta PK, Feuermann Y, Kaphzan H. Dynamic shift in localization of UBE3A across developmental stages in an Angelman syndrome mouse model. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2025.106912
BibTeX
@article{Gupta2025,
author = {Gupta, Pooja Kri and Feuermann, Yonatan and Kaphzan, Hanoch},
title = {Dynamic shift in localization of UBE3A across developmental stages in an Angelman syndrome mouse model},
journal = {Neurobiology of Disease},
year = {2025},
doi = {10.1016/j.nbd.2025.106912}
}
EUVIMED